← Alle mensen

HA

Hiroaki Akamatsu

8 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-11

Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-smal...

European journal of cancer (Oxford, England : 1990) · 9 september 2025

Eerstelijns Lorlatinib Versus Crizotinib in Asian Patiënten met Gevorderd ALK-Positive NSCLC: Five-Year Outcomes From...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-07

Pragmatic Gerandomiseerde Study of Afatinib Versus Chemotherapy for Patiënten met Non-Small Cell Lung Cancer With Unc...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 juni 2025

Subcutaan versus IV amivantamab plus lazertinib bij EGFR-gemuteerd NSCLC: PALOMA-3

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2024

Perioperatieve durvalumab bij resectabel NSCLC: AEGEAN fase III

The New England journal of medicine · 2 november 2023

Osimertinib plus bevacizumab versus osimertinib bij T790M NSCLC

JAMA oncology · 1 maart 2021

Osimertinib versus platina-pemetrexed bij EGFR T790M-positief longcarcinoom: AURA3-studie

The New England journal of medicine · 16 februari 2017